251 related articles for article (PubMed ID: 26610276)
1. The role of uric acid in chronic kidney disease patients.
Hsieh YP; Chang CC; Yang Y; Wen YK; Chiu PF; Lin CC
Nephrology (Carlton); 2017 Jun; 22(6):441-448. PubMed ID: 26610276
[TBL] [Abstract][Full Text] [Related]
2. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
[TBL] [Abstract][Full Text] [Related]
3. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality.
Liu WC; Hung CC; Chen SC; Yeh SM; Lin MY; Chiu YW; Kuo MC; Chang JM; Hwang SJ; Chen HC
Clin J Am Soc Nephrol; 2012 Apr; 7(4):541-8. PubMed ID: 22300737
[TBL] [Abstract][Full Text] [Related]
4. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
Srivastava A; Kaze AD; McMullan CJ; Isakova T; Waikar SS
Am J Kidney Dis; 2018 Mar; 71(3):362-370. PubMed ID: 29132945
[TBL] [Abstract][Full Text] [Related]
5. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K
J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499
[TBL] [Abstract][Full Text] [Related]
6. Effects of hyperuricemia on incident renal replacement therapy and all-cause mortality among patients with chronic kidney disease stages 3-5: a retrospective cohort study.
Lee CL; Wang JS
Sao Paulo Med J; 2019; 137(6):523-529. PubMed ID: 32159639
[TBL] [Abstract][Full Text] [Related]
7. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.
Wang S; Shu Z; Tao Q; Yu C; Zhan S; Li L
Nephrology (Carlton); 2011 Nov; 16(8):767-76. PubMed ID: 21854506
[TBL] [Abstract][Full Text] [Related]
8. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
[TBL] [Abstract][Full Text] [Related]
9. Serum uric acid levels and long-term outcomes in chronic kidney disease.
Miyaoka T; Mochizuki T; Takei T; Tsuchiya K; Nitta K
Heart Vessels; 2014 Jul; 29(4):504-12. PubMed ID: 23929090
[TBL] [Abstract][Full Text] [Related]
10. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
[TBL] [Abstract][Full Text] [Related]
11. J-shaped mortality relationship for uric acid in CKD.
Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
[TBL] [Abstract][Full Text] [Related]
12. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
Chen SC; Chang JM; Yeh SM; Su HM; Chen HC
Am J Hypertens; 2013 Feb; 26(2):243-9. PubMed ID: 23382409
[TBL] [Abstract][Full Text] [Related]
13. Effects of uric acid on kidney function decline differ depending on baseline kidney function in type 2 diabetic patients.
Hanai K; Tauchi E; Nishiwaki Y; Mori T; Yokoyama Y; Uchigata Y; Babazono T
Nephrol Dial Transplant; 2019 Aug; 34(8):1328-1335. PubMed ID: 29860523
[TBL] [Abstract][Full Text] [Related]
14. Association of serum sodium levels with all-cause and cardiovascular mortality in chronic kidney disease: Results from a prospective observational study.
Chiu DY; Kalra PA; Sinha S; Green D
Nephrology (Carlton); 2016 Jun; 21(6):476-82. PubMed ID: 26426983
[TBL] [Abstract][Full Text] [Related]
15. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
[TBL] [Abstract][Full Text] [Related]
16. Impact of Uric Acid Levels on Kidney Disease Progression.
Rincon-Choles H; Jolly SE; Arrigain S; Konig V; Schold JD; Nakhoul G; Navaneethan SD; Nally JV; Rothberg MB
Am J Nephrol; 2017; 46(4):315-322. PubMed ID: 29032376
[TBL] [Abstract][Full Text] [Related]
17. Association of serum uric acid with all-cause and cardiovascular mortality in chronic kidney disease stages 3-5.
Yuan J; Zhao J; Qin Y; Xing Y; Yu Z; Zhang Y; Wu H; Zheng Q; Hui Y; Guo S; Wang A; Han M; Ning X; Sun S
Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1518-1527. PubMed ID: 38508991
[TBL] [Abstract][Full Text] [Related]
18. Uric acid and long-term outcomes in CKD.
Madero M; Sarnak MJ; Wang X; Greene T; Beck GJ; Kusek JW; Collins AJ; Levey AS; Menon V
Am J Kidney Dis; 2009 May; 53(5):796-803. PubMed ID: 19303683
[TBL] [Abstract][Full Text] [Related]
19. Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease.
Misra S; Khosla A; Allred J; Harmsen WS; Textor SC; McKusick MA
J Vasc Interv Radiol; 2016 Aug; 27(8):1215-24. PubMed ID: 27296703
[TBL] [Abstract][Full Text] [Related]
20. Vascular calcification in patients with nondialysis CKD over 3 years.
Górriz JL; Molina P; Cerverón MJ; Vila R; Bover J; Nieto J; Barril G; Martínez-Castelao A; Fernández E; Escudero V; Piñera C; Adragao T; Navarro-Gonzalez JF; Molinero LM; Castro-Alonso C; Pallardó LM; Jamal SA
Clin J Am Soc Nephrol; 2015 Apr; 10(4):654-66. PubMed ID: 25770175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
